The common pathways and targeted drugs for psoriasis and inflammatory bowel disease
The increasing evidence showed that psoriasis and inflammatory bowel disease are now considered as chronic systemic inflammatory diseases, and they are comorbidities for each other. Due to multiply overlapping pathophysiological mechanisms, drugs targeting to their common pathways have become hot sp...
Saved in:
Main Authors: | Jinsheng LI (Author), Yaqian ZHU (Author), Yongfeng CHEN (Author) |
---|---|
Format: | Book |
Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psoriasis and inflammatory bowel disease: links and risks
by: Vlachos C, et al.
Published: (2016) -
The most common dermatological manifestations of inflammatory bowel diseases
by: Izabela Hop, et al.
Published: (2023) -
Key genes and pathways involved in the pathogenesis of pemphigus foliaceus: Based on bioinformatic studies
by: Yaqian ZHU, et al.
Published: (2023) -
The importance of screening for inflammatory bowel disease in patients with psoriasis and psoriatic arthritis
by: Isabella Aldana, et al.
Published: (2022) -
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
by: Keira A Fieldhouse, et al.
Published: (2020)